Krka d. d (KRK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Krka d. d (KRK) has a cash flow conversion efficiency ratio of 0.062x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł146.54 Million ≈ $40.33 Million USD) by net assets (zł2.38 Billion ≈ $654.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See KRK defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Krka d. d - Cash Flow Conversion Efficiency Trend (2010–2025)
This chart illustrates how Krka d. d's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Krka d. d Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Krka d. d ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SKANSKA AB (SPONS.ADR)/1
F:SKN
|
0.064x |
|
China Zheshang Bank Co Ltd
SHG:601916
|
-0.430x |
|
Macronix International Co Ltd
TW:2337
|
0.045x |
|
Autoliv Inc
ST:ALIV-SDB
|
-0.028x |
|
LPP S.A.
WAR:LPP
|
0.432x |
|
GameStop Corp.
NYSE:GME
|
0.036x |
|
Weichai Power Co. Ltd
F:WI4
|
0.057x |
|
Hindustan Petroleum Corporation Limited
NSE:HINDPETRO
|
0.336x |
Annual Cash Flow Conversion Efficiency for Krka d. d (2010–2025)
The table below shows the annual cash flow conversion efficiency of Krka d. d from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see KRK company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | zł2.38 Billion ≈ $654.23 Million |
zł528.62 Million ≈ $145.48 Million |
0.222x | +37.87% |
| 2024-12-31 | zł2.24 Billion ≈ $615.87 Million |
zł360.93 Million ≈ $99.33 Million |
0.161x | +54.85% |
| 2023-12-31 | zł2.18 Billion ≈ $600.45 Million |
zł227.25 Million ≈ $62.54 Million |
0.104x | -52.37% |
| 2022-12-31 | zł2.14 Billion ≈ $588.55 Million |
zł467.65 Million ≈ $128.70 Million |
0.219x | +8.69% |
| 2021-12-31 | zł1.92 Billion ≈ $528.16 Million |
zł386.10 Million ≈ $106.26 Million |
0.201x | -2.30% |
| 2020-12-31 | zł1.75 Billion ≈ $482.12 Million |
zł360.76 Million ≈ $99.29 Million |
0.206x | -1.75% |
| 2019-12-31 | zł1.67 Billion ≈ $458.92 Million |
zł349.52 Million ≈ $96.19 Million |
0.210x | +11.35% |
| 2018-12-31 | zł1.54 Billion ≈ $423.90 Million |
zł289.95 Million ≈ $79.80 Million |
0.188x | +22.92% |
| 2017-12-31 | zł1.49 Billion ≈ $409.44 Million |
zł227.83 Million ≈ $62.70 Million |
0.153x | +3.61% |
| 2016-12-31 | zł1.44 Billion ≈ $397.53 Million |
zł213.49 Million ≈ $58.76 Million |
0.148x | -25.23% |
| 2015-12-31 | zł1.41 Billion ≈ $386.95 Million |
zł277.94 Million ≈ $76.49 Million |
0.198x | +56.41% |
| 2014-12-31 | zł1.35 Billion ≈ $372.06 Million |
zł170.87 Million ≈ $47.03 Million |
0.126x | -44.37% |
| 2013-12-31 | zł1.33 Billion ≈ $366.75 Million |
zł302.75 Million ≈ $83.32 Million |
0.227x | +1.26% |
| 2012-12-31 | zł1.24 Billion ≈ $341.41 Million |
zł278.33 Million ≈ $76.60 Million |
0.224x | +3.51% |
| 2011-12-31 | zł1.14 Billion ≈ $313.68 Million |
zł247.06 Million ≈ $67.99 Million |
0.217x | +25.79% |
| 2010-12-31 | zł1.05 Billion ≈ $289.89 Million |
zł181.52 Million ≈ $49.96 Million |
0.172x | -- |
About Krka d. d
Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company offers prescription pharmaceuticals for cardiovascular, central nervous system, gastrointestinal tract, pain, diabetes, an… Read more